Animalcare Group (ANCR) Competitors GBX 254.20 -1.80 (-0.70%) As of 05/21/2025 12:12 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesBuy This Stock ANCR vs. AMYT, AGY, APH, VLG, DNL, EAH, STX, PXS, CHLL, and MXCShould you be buying Animalcare Group stock or one of its competitors? The main competitors of Animalcare Group include Amryt Pharma (AMYT), Allergy Therapeutics (AGY), Alliance Pharma (APH), Venture Life Group (VLG), Diurnal Group (DNL), ECO Animal Health Group (EAH), Shield Therapeutics (STX), Provexis (PXS), Chill Brands Group (CHLL), and Argent BioPharma (MXC). These companies are all part of the "drug manufacturers - specialty & generic" industry. Animalcare Group vs. Amryt Pharma Allergy Therapeutics Alliance Pharma Venture Life Group Diurnal Group ECO Animal Health Group Shield Therapeutics Provexis Chill Brands Group Argent BioPharma Amryt Pharma (LON:AMYT) and Animalcare Group (LON:ANCR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, community ranking, profitability, risk, analyst recommendations, dividends and media sentiment. Does the media refer more to AMYT or ANCR? In the previous week, Animalcare Group had 1 more articles in the media than Amryt Pharma. MarketBeat recorded 1 mentions for Animalcare Group and 0 mentions for Amryt Pharma. Amryt Pharma's average media sentiment score of 0.00 equaled Animalcare Group'saverage media sentiment score. Company Overall Sentiment Amryt Pharma Neutral Animalcare Group Neutral Does the MarketBeat Community prefer AMYT or ANCR? Amryt Pharma received 89 more outperform votes than Animalcare Group when rated by MarketBeat users. However, 69.37% of users gave Animalcare Group an outperform vote while only 65.68% of users gave Amryt Pharma an outperform vote. CompanyUnderperformOutperformAmryt PharmaOutperform Votes24365.68% Underperform Votes12734.32% Animalcare GroupOutperform Votes15469.37% Underperform Votes6830.63% Do insiders & institutionals have more ownership in AMYT or ANCR? 49.0% of Animalcare Group shares are held by institutional investors. 29.5% of Animalcare Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has better valuation & earnings, AMYT or ANCR? Animalcare Group has lower revenue, but higher earnings than Amryt Pharma. Amryt Pharma is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmryt Pharma£210.24M0.00N/A-£33.00N/AAnimalcare Group£84.90M2.05£36.55M£53.644.74 Is AMYT or ANCR more profitable? Animalcare Group has a net margin of 43.05% compared to Amryt Pharma's net margin of 0.00%. Animalcare Group's return on equity of 36.62% beat Amryt Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Amryt PharmaN/A N/A N/A Animalcare Group 43.05%36.62%2.97% SummaryAnimalcare Group beats Amryt Pharma on 9 of the 11 factors compared between the two stocks. Get Animalcare Group News Delivered to You Automatically Sign up to receive the latest news and ratings for ANCR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANCR vs. The Competition Export to ExcelMetricAnimalcare GroupDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£174.28M£2.17B£5.37B£2.68BDividend Yield2.05%2.92%5.22%5.05%P/E Ratio4.743.9926.84134.32Price / Sales2.05529.96392.34203,702.46Price / Cash26.0510.2538.2528.02Price / Book1.576.926.793.79Net Income£36.55M£20.70B£3.23B£5.89B7 Day Performance3.54%-0.39%1.53%0.65%1 Month Performance12.14%4.82%10.06%22.12%1 Year Performance5.71%89.73%16.72%119.61% Animalcare Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANCRAnimalcare GroupN/AGBX 254.20-0.7%N/A+4.2%£174.28M£84.90M4.74220Gap UpAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownAGYAllergy TherapeuticsN/AGBX 7.20-2.0%N/A+105.9%£353.89M£72.18M-6.94612Gap UpHigh Trading VolumeAPHAlliance Pharma1.8565 of 5 starsGBX 64.60flatGBX 6,250+9,574.9%N/A£349.77M£183.50M-10.4191,000High Trading VolumeVLGVenture Life GroupN/AGBX 45flatN/A+29.8%£57.34M£51.77M76.37165News CoverageGap UpHigh Trading VolumeDNLDiurnal GroupN/AN/AN/AN/A£46.33M£4.68M-3.2133EAHECO Animal Health GroupN/AGBX 63-3.1%N/A-47.2%£42.69M£89.44M40.72234Gap DownSTXShield TherapeuticsN/AGBX 2.54-0.4%N/A+23.1%£25.07M£20.92M-0.6540,000PXSProvexisN/AGBX 0.59+2.1%N/A-4.8%£13.73M£846,984.38-22.184Gap DownCHLLChill Brands GroupN/AN/AN/AN/A£10.89M£624,187.00-215.007MXCArgent BioPharmaN/AN/AN/AN/A£9.65M£1.32M-13.255Gap Up Related Companies and Tools Related Companies Amryt Pharma Alternatives Allergy Therapeutics Alternatives Alliance Pharma Alternatives Venture Life Group Alternatives Diurnal Group Alternatives ECO Animal Health Group Alternatives Shield Therapeutics Alternatives Provexis Alternatives Chill Brands Group Alternatives Argent BioPharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:ANCR) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Animalcare Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Animalcare Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.